Unit Converter
IGF-1 – Insulin-like growth factor 1 (Somatomedin C)

SI UNITS (recommended)

CONVENTIONAL UNITS

Synonyms

  • IGF-1
  • Insulin-like Growth Factor 1
  • Somatomedin-C
  • Growth-promoting peptide
  • SM-C
  • Serum IGF-1

Units of Measurement

  • nmol/L
  • µg/L
  • µg/dL
  • µg/100 mL
  • µg%
  • ng/mL

Key Conversions

(Molecular Weight ≈ 7649 Da ≈ 7.65 kDa)

1 ng/mL = 1 µg/L
1 µg/L ≈ 0.13 nmol/L
1 nmol/L ≈ 7.65 µg/L
1 µg/dL = 10 µg/L = 10 ng/mL
µg/100 mL = µg/dL = µg%

Description

IGF-1 is a polypeptide hormone mainly produced by the liver in response to growth hormone (GH) stimulation.

KEY PROPERTIES:

  • Stable and non-pulsatile
  • Reflects integrated GH secretion
  • Age-dependent
  • Strongly influenced by nutrition, liver function, and chronic illness

IGF-1 binds to IGF-binding proteins (IGFBPs), especially IGFBP-3, forming IGF-1/IGFBP-3/ALS complexes circulating in blood.

Physiological Role

IGF-1 mediates MANY actions of GH:

1. Linear Growth

  • Promotes epiphyseal growth plate expansion
  • Drives chondrocyte proliferation

2. Anabolism

  • Protein synthesis
  • Muscle growth
  • Organ development

3. Metabolic Effects

  • Insulin-like glucose uptake
  • Lipid metabolism

4. Cell Survival & Repair

  • Anti-apoptotic effects
  • Tissue regeneration

Clinical Significance

HIGH IGF-1

1. Acromegaly (Adults) / Gigantism (Children)

  • PRIMARY screening test for acromegaly
  • Elevated IGF-1 in >95% of cases
  • Must be confirmed with GH suppression test (OGTT)

Features:

  • Enlarged hands/feet
  • Jaw prognathism
  • Soft-tissue overgrowth
  • Hypertension
  • DM / insulin resistance

2. Puberty

Physiological peak.

3. High Protein Intake

Nutritional stimulation.

4. Pregnancy

Mild physiologic increase.

5. Rare Tumors

  • IGF-1–secreting tumors (very rare)
  • Some Ewing sarcomas and Wilms tumors (rare associations)

LOW IGF-1

1. Growth Hormone Deficiency (GHD)

Best screening test for:

  • Pediatric GHD
  • Adult GHD
    Low IGF-1 + failed stimulation test = GH deficiency.

2. Chronic Systemic Disease

  • Malnutrition
  • Chronic liver disease
  • CKD
  • Inflammatory diseases
  • Celiac disease

3. Hypothyroidism

Reduces IGF-1 production.

4. Diabetes / Poor Glycemic Control

Low–normal IGF-1.

5. Aging

Levels decline with age.

Reference Intervals

Values vary widely; always use age-adjusted z-score.

Typical Adult Values:

  • 20–40 years: 120–360 µg/L
  • 40–60 years: 80–250 µg/L
  • >60 years: 50–200 µg/L

Children & Adolescents:

  • Peaks during puberty: 300–1200 µg/L
  • Lowest in toddlers and elderly.

Acromegaly Cutoffs

  • IGF-1 above age-adjusted upper limit → suspect acromegaly
  • Confirm with OGTT GH suppression (<1 ng/mL or <0.4 ng/mL ultrasensitive)

GH Deficiency

  • IGF-1 below -2 SD for age
  • Confirm with GH stimulation testing.

Diagnostic Uses

1. Screening for Acromegaly

IGF-1 elevated → do GH suppression test.

2. Diagnosis of Growth Hormone Deficiency

Low IGF-1 + failed stimulation test.

3. Monitoring GH Therapy

In both children and adults:

  • Titrate GH dose using IGF-1 target range (normal for age).

4. Pediatric Growth Disorders

  • Short stature
  • Constitutional delay
  • Poor weight/height velocity

5. Liver Disease / Nutrition Assessment

IGF-1 reflects:

  • Liver synthetic function
  • Protein nutrition status
  • Chronic illness burden

Analytical Notes

  • Fasting not required
  • Serum or plasma acceptable
  • MUST interpret with age- and sex-matched reference ranges
  • Biotin supplements may interfere with immunoassays
  • IGF-1 stable after collection; minimal pre-analytical issues
  • Use same assay for serial monitoring

Clinical Pearls

  • IGF-1 is far more stable than GH → ideal for screening.
  • Low IGF-1 does NOT necessarily mean GH deficiency - check:
    • Liver disease
    • Malnutrition
    • Hypothyroidism
    • Chronic inflammation
  • GH excess rarely shows normal IGF-1 (high sensitivity).
  • In acromegaly monitoring, IGF-1 normalization = biochemical control.
  • IGF-1 is a better marker than GH for assessing adequacy of GH therapy.

Interesting Fact

Although GH pulses occur every 2–3 hours, IGF-1 remains stable throughout the day, which is why it revolutionized acromegaly diagnosis when introduced.

References

  1. Tietz Clinical Chemistry & Molecular Diagnostics, 8th Edition - IGF-1.
  2. Endocrine Society Guidelines - Acromegaly & GH Deficiency.
  3. Pediatric Endocrine Society - GH/IGF-1 Testing.
  4. Mayo Clinic Laboratories - IGF-1.
  5. ARUP Consult - GH & IGF-1 Interpretation.
  6. MedlinePlus / NIH - IGF-1 Test.

Last updated: January 26, 2026

Reviewed by : Medical Review Board

Change language

Other Convertors